Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards
Hummingbird Bioscience has won the Asia Pacific Trailblazer Award at the 2026 AI Discovery Awards…
Continue Reading-
-
Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies
Hummingbird Bioscience, a biotherapeutics company discovering and developing transformative medicines for diseases with significant unmet…
Continue Reading
